Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
CNY 62.26
(-0.91%)
CNY 62.26
(-0.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.63 Billion | 2.1 Billion | 1.75 Billion | 1.32 Billion | 1.59 Billion | 1.54 Billion |
| Cost of Revenue | 781.4 Million | 656.51 Million | 490.37 Million | 334 Million | 363.99 Million | 334.28 Million |
| Gross Profit | 1.85 Billion | 1.44 Billion | 1.25 Billion | 990.42 Million | 1.23 Billion | 1.21 Billion |
| Operating Expenses | 1.45 Billion | 1.22 Billion | 1.03 Billion | 865.07 Million | 929.18 Million | 768.41 Million |
| Selling, General and Administrative Expenses | 1.23 Billion | 1.08 Billion | 898.43 Million | 772.48 Million | 813.11 Million | 737.48 Million |
| Research and Development Expenses | 220.09 Million | 182.19 Million | 167.59 Million | 126.47 Million | 116.07 Million | 95.37 Million |
| Other Expenses | -114.81 Million | -40.27 Million | -33.88 Million | -33.88 Million | 107.74 Million | 341 Thousand |
| Cost and Expenses | 2.14 Billion | 1.88 Billion | 1.52 Billion | 1.19 Billion | 1.29 Billion | 1.1 Billion |
| Operating Income | 507.41 Million | 258.66 Million | 384.43 Million | 260.56 Million | 437.96 Million | 443.12 Million |
| Interest Expense | 7.29 Million | 7.6 Million | 4.96 Million | 4.9 Million | 4.53 Million | 2.14 Million |
| Income Tax Expense | 95.99 Million | 45.39 Million | 35.36 Million | 30.68 Million | 57.97 Million | 70.1 Million |
| Earnings before Tax | 507.8 Million | 235.72 Million | 382.64 Million | 257.02 Million | 434.34 Million | 525.18 Million |
| Net Income | 416.12 Million | 180.47 Million | 352.23 Million | 230.07 Million | 370.77 Million | 414.54 Million |
| Earnings Per Share Basic | 1.74 | 1.04 | 2.00 | 1.30 | 2.08 | 2.59 |
| Earnings Per Share Diluted | 1.74 | 1.04 | 2.00 | 1.30 | 2.08 | 2.59 |
| Weighted Average Shares Outstanding | 238.74 Million | 173.52 Million | 176.12 Million | 176.97 Million | 177.84 Million | 160.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 238.74 Million | 173.52 Million | 176.12 Million | 176.97 Million | 177.84 Million | 160.04 Million |
| Gross Margin | 0.70 | 0.69 | 0.72 | 0.75 | 0.77 | 0.78 |
| EBIT Margin | 0.27 | 0.22 | 0.31 | 0.30 | 0.35 | 0.40 |
| Profit Margin | 0.16 | 0.09 | 0.20 | 0.17 | 0.23 | 0.27 |
| EBITDA | 712.95 Million | 444.04 Million | 548.25 Million | 394.8 Million | 554.31 Million | 600.47 Million |
| Earnings Before Tax Margin | 0.19 | 0.12 | 0.22 | 0.20 | 0.27 | 0.29 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 665.93 Million | 754.08 Million | 642.79 Million | 2.63 Billion | 666.69 Million | 676.08 Million |
| Cost of Revenue | 199.67 Million | 249.41 Million | 198.87 Million | 781.4 Million | 256.94 Million | 182.6 Million |
| Gross Profit | 466.26 Million | 504.66 Million | 443.92 Million | 1.85 Billion | 409.75 Million | 493.47 Million |
| Operating Expenses | 369.41 Million | 370.46 Million | 346.62 Million | 1.45 Billion | 320.33 Million | 400.98 Million |
| Selling, General and Administrative Expenses | 306.06 Million | 303.12 Million | 282.29 Million | - | 255.23 Million | 317.55 Million |
| Research and Development Expenses | 62.73 Million | 55.2 Million | 64.9 Million | - | 63.21 Million | 52.76 Million |
| Other Expenses | -614.88 Thousand | -12.13 Million | 565.44 Thousand | -4.03 Million | -1.88 Million | 5.55 Million |
| Cost and Expenses | 569.09 Million | 619.88 Million | 545.49 Million | 2.23 Billion | 577.27 Million | 583.59 Million |
| Operating Income | 96.84 Million | 134.2 Million | 97.29 Million | 398.53 Million | 89.41 Million | 138.92 Million |
| Interest Expense | 1.45 Million | 4.85 Million | 2.67 Million | 7.29 Million | 2.73 Million | 889.32 Thousand |
| Income Tax Expense | 25.62 Million | 23.15 Million | 21.67 Million | 95.99 Million | 33.6 Million | 21.27 Million |
| Earnings before Tax | 124.17 Million | 148.05 Million | 114.13 Million | 507.8 Million | 118.97 Million | 139.55 Million |
| Net Income | 105.6 Million | 137.74 Million | 97.54 Million | 416.12 Million | 89.31 Million | 121.56 Million |
| Earnings Per Share Basic | 0.45 | 0.59 | 0.59 | - | 0.53 | 0.71 |
| Earnings Per Share Diluted | 0.45 | 0.59 | 0.59 | - | 0.53 | 0.71 |
| Weighted Average Shares Outstanding | 233.2 Million | 233.69 Million | 165.41 Million | 170.53 Million | 168.52 Million | 171.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 233.2 Million | 233.69 Million | 165.41 Million | 170.53 Million | 168.52 Million | 171.22 Million |
| Gross Margin | 0.70 | 0.67 | 0.69 | 0.70 | 0.61 | 0.73 |
| EBIT Margin | 0.19 | 0.24 | 0.18 | - | 0.21 | 0.21 |
| Profit Margin | 0.16 | 0.18 | 0.15 | 0.16 | 0.13 | 0.18 |
| EBITDA | 125.62 Million | 183.49 Million | 117.24 Million | - | 137.57 Million | 138.92 Million |
| Earnings Before Tax Margin | 0.15 | 0.18 | 0.15 | 0.15 | 0.13 | 0.21 |
BETS-B
249420
GMTD
KAZT
CNBW
600219